No Detail Found!

Critical Update for the Treatment of Anemia by using Advanced Genome Editing Crispr Cas Technology

Author(s)
Ghulam Akbar Department of Biochemistry, University of Agriculture, Faisalabad, 38000, Pakistan
Ali Ahmad Department of Agronomy, University of Agriculture, Faisalabad, 38000, Pakistan
Neha Arooj Department of Biochemistry, University of Agriculture, Faisalabad, 38000, Pakistan
Muhammad Anjum Zia Department of Biochemistry, University of Agriculture, Faisalabad, 38000, Pakistan
Aamna Rafique Department of Biochemistry, University of Agriculture, Faisalabad, 38000, Pakistan
Sania Riasat Department of Biochemistry, University of Agriculture, Faisalabad, 38000, Pakistan
Mohsin Raza Department of Biochemistry, University of Agriculture, Faisalabad, 38000, Pakistan
Mahpara Qamar Department of Biochemistry, University of Agriculture, Faisalabad, 38000, Pakistan
Shahneela Nusrat Department of Biochemistry, University of Agriculture, Faisalabad, 38000, Pakistan
Shakila Hanif Department of Biochemistry, University of Agriculture, Faisalabad, 38000, Pakistan
Abstract
Anemia is the condition which results in formation of unhealthy red blood cells which results lack of oxygen supply towards tissues of body. It is common and worldwide problem that associates with all ages like pregnant women, children and aged people. Anemia  associated  with  numerous  infectious and continual problems such as persistent kidney disease, cancer, ischemic heart ailment and inflammatory bowel disorder. However, with the development in generation at genome editing level have made feasible to accurate mutations in human genome. A site oriented specific break in double stranded DNA is induced by CRISPR/Cas9, whereas diferent oligonucleotides are provided to make accurate DNA template for genome correction. It is of importance to knowledge about types of CRISPR to treat anemia. Cas 9 showed one of best gene editing reactions than others. Recent data gives authentic applications of CRISPR use in anemia which provides potential for usage of gene editing technique for diferent types of anemia. In evaluation we defined currently developed genome editing device update used for the remedy of anemia, its mechanism of movement and sickle cellular mutation corrections.
Publication Details
Page(s) 144-149
DOI DOI not available
Published Journal: Journal of Innovative Sciences, Volume: 6, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
genome, CRISPR Cas, Mutation corrections, Anemia updates
0

Citations

0

Downloads

55

Views